🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Experimental Treatment Gaining Popularity Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to contact these accounts directly for supplier links, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing trade exists on messaging services, where communities with thousands of members share comparison photos, injection guides and claims of rapid British shipping. Sellers market the drug there before redirecting customers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Worries

Nevertheless, physicians and chemists have warned that the distribution of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals injecting products of unknown origin.

Some experts said the popularity for the experimental drug could be linked to the increasing price of approved slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the British medical regulations.

Several content creators try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still breach medicines, marketing, and customer regulations, risking penalties, legal action or prison.

Service Reaction and Material Elimination

According to the social media company, the service has taken down problematic content and prohibited related hashtags and query recommendations. The company stated it was committed to keeping the service safe and allocating resources in strengthening compliance measures.

Digital Marketplace Operations

Research also found communities with up to 9,000 participants selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with numerous of users, filled with images of weight loss, glowing testimonials and step-by-step guides for mixing or administering at home.

After moments of entering one community, a vendor shared contact information, where the majority of transactions occur. The vendor provided an instruction manual and promised shipping within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None inquired about weight, health issues or previous experience.

Item Information and Pricing

Inside these groups, messages show black plastic parcels with Royal Mail stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use pens typically priced at £160 for 20mg. When questioned how long a pen should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for Telegram said it regularly moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they can’t verify. Even if the science behind this drug is valid, these online products may not include what they advertise,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are turning to social media. But fake injections are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has already seen individuals injured by self-injection from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to possibly serious health risks”.